Publication:
Postoperative Hemodynamic Stabilization with Terlipressin: A Case of Liver Transplantation

Simple item page
dc.authorscopusid56458963100
dc.authorscopusid57217675736
dc.authorscopusid58972636400
dc.authorscopusid57971286800
dc.authorscopusid22942100300
dc.contributor.authorÜnal Akdemir, N.
dc.contributor.authorÇolak, Ö.Y.
dc.contributor.authorİŞevi, M.
dc.contributor.authorSezer Akman, T.
dc.contributor.authorÜlger, F.
dc.date.accessioned2025-12-11T00:34:38Z
dc.date.issued2025
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ünal Akdemir] Neslihan, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Çolak] Özkul Yılmaz, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [İŞevi] Melda, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Sezer Akman] Tuğçehan, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Ülger] Fatma Esra Bahadır, Department of Anesthesiology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractThis report presents the successful management of a patient with acute liver failure on the background of chronic liver disease who underwent liver transplantation. Terlipressin, a vasoactive agent, managed hepatorenal syndrome and acute kidney injury by promoting splanchnic vasoconstriction and intrahepatic vasodilation, improving renal blood flow and hemodynamic stability. The case involves a 41-year-old woman with autoimmune hepatitis and primary biliary cirrhosis who required triple vasoactive therapy postoperatively. Bolus doses of terlipressin reduced the need for other vasopressors, stabilized renal function, and facilitated her recovery. This case underscores the potential of terlipressin as a valuable therapeutic option in the postoperative management of liver transplantation patients with refractory hemodynamic instability. Careful dosing and monitoring are essential to optimize outcomes and minimize risks. © 2025 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.42.1.20
dc.identifier.endpage100en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-105002153831
dc.identifier.scopusqualityQ4
dc.identifier.startpage98en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.42.1.20
dc.identifier.urihttps://hdl.handle.net/20.500.12712/37645
dc.identifier.volume42en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Üniversitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatorenal Syndromeen_US
dc.subjectLiver Transplantationen_US
dc.subjectTerlipressinen_US
dc.titlePostoperative Hemodynamic Stabilization with Terlipressin: A Case of Liver Transplantationen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu